InvestorsHub Logo
Followers 14
Posts 838
Boards Moderated 0
Alias Born 08/22/2009

Re: None

Monday, 09/10/2018 5:54:02 PM

Monday, September 10, 2018 5:54:02 PM

Post# of 625
From another board..good summary of last quarter.


(from https://globenewswire.com/news-release/2018/06/28/1530867/0/en/Hydropothecary-reports-fiscal-2018-third-quarter-results.html )
Highlights for 3rd Quarter Ending April 30 2018

Revenue per gram increased to $9.24 per gram equivalent from $8.99 in the prior quarter, and $8.62 in the third quarter of fiscal 2017.
Weighted average cash cost of dried inventory sold per gram of $0.88 has decreased 57% year-over-year compared to the third quarter of fiscal 2017.
Revenue increased 5% to $1,240,172 and the volume of medical cannabis sold increased 2% to 134,253 gram equivalents from the second quarter of fiscal 2018.
Finalization of the commercial supplier agreement with Socit qubcoise du cannabis (SQDC) to supply approximately 200,000 kg of cannabis over a five-year term.
20,000 kg of cannabis to be supplied to the SQDC in year one of the supplier agreement post legalization.
Cash and short-term investments of $248.9 million as at April 30, 2018, debt-free balance sheet.
Launch of the new recreational adult-use cannabis brand HEXO.
First plants planted in newly licensed zones of the new 250,000 sq. ft facility.
Graduated to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSXV) with the common shares now trading under the symbol HEXO.
Announcement of intention to change the Company name to HEXO Corp. from the Hydropothecary Corporation.

Read more at http://www.stockhouse.com/companies/bullboard/t.hexo/the-hydropothecary-corp?postid=28593106#u6l2EL8BwTjwuMTH.99
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEXO News